MagnEtophoretic Slider Assay (MeSA): A simple platform for point-of-care diagnostics

Author:

Call Zachary D.,Dolence Alli,Boes Jason,Henry Charles S.

Abstract

Infectious diseases account for millions of deaths each year. To reduce the number of infectious disease related deaths, diagnostic testing needs to be more accessible to patients in low-income countries as well as developed countries. Current diagnostic methods involve centralized laboratories, trained personnel, and are time-intensive, limiting translation to the point-of-care (POC). Microfluidic devices are a popular alternative for diagnostics due to reduced assay times, reduced sample volume, and lower cost. Microfluidic devices are small (<10 cm) and can perform complex assays. Microfluidic paper-based analytical devices (µPADs) are a popular approach to help translate diagnostics to the POC but historically suffer from poor sensitivity when compared to established laboratory methods. Magnetically labeling analytes allows samples to be sorted resulting in improved sensitivity and specificity. Microfluidic magnetophoresis is the process of manipulating magnetic particles in a magnetic field and offers the ability to wash and concentrate a sample during flow. However, until recently, magnetophoresis has not been used in conjunction with µPADs because magnetophoresis requires complex and expensive instrumentation to control flow. Coupling magnetophoresis with µPADs enables pump-free flow control, simple operation, and low cost. Early magnetophoresis µPADs showed detection limits similar to traditional methods but higher than targets for clinical use. In this work, we demonstrate a novel, simple MagnEtophoretic Slider Assay (MeSA) that is free of any external instrumentation and offers a new platform for POC diagnostics. We demonstrate the assay’s capability through biotin competitive assays and a sandwich immunoassay for E. coli detection. The calculated limit of detection for E. coli was 1.62 × 103 Colony Forming Units per mL (CFU/ml). The work described is a novel and simple microfluidic platform that has potential for a wide range of future applications.

Publisher

Frontiers Media SA

Subject

General Medicine,General Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3